Shilpa Rao

1.1k citations
86 papers · 755 indexed · h-index 11
Topics
Glioma Diagnosis and Treatment (31 papers)Pituitary Gland Disorders and Treatments (8 papers)Sarcoma Diagnosis and Treatment (7 papers)
Journals
Proceedings of the National Academy of SciencesSHILAP Revista de lepidopterologíaCell Metabolism

In The Last Decade

Shilpa Rao

70 papers receiving 746 citations

Peers

Shilpa Rao
Comparison fields: 5 of 89
  • Molecular Biology 348
  • Cancer Research 178
  • Surgery 172
  • Genetics 138
  • Genetics 96
Replace Weiqiang Li with:
Weiqiang Li China
Sepideh Alavi-Moghadam Iran
Zhao Cheng China
Marta García-Contreras United States
Vishnu Chintalgattu United States
Hiroshi Koriyama Japan
Xiaodan Jiang China
Hui Wei China
Fernando J. Rossello Australia
Lei Lei China
Shilpa Rao relative to Weiqiang Li China Weiqiang Li's profile →
Citations per field
00.5×1.5×1.8×
Weiqiang Li · 1×
Citations per year

Countries citing papers authored by Shilpa Rao

Since Specialization
Citations

This map shows the geographic impact of Shilpa Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilpa Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilpa Rao more than expected).

Fields of papers citing papers by Shilpa Rao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilpa Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilpa Rao. The network helps show where Shilpa Rao may publish in the future.

Co-authorship network of co-authors of Shilpa Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Shilpa Rao. A scholar is included among the top collaborators of Shilpa Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilpa Rao. Shilpa Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 1
5 0
6 1
7 1
8 1
9 1
10 2
11 2
12 1
13 9
14 3
15 4
16 7
17 4
18 20
19 148
20 68

About Shilpa Rao

Shilpa Rao is a scholar working on Genetics, Microbiology and Neurology, having authored 86 papers that have together received 755 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (31 papers), Pituitary Gland Disorders and Treatments (8 papers) and Sarcoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Genetics (138 citations), Cancer Research (178 citations) and Aging (14 citations). Shilpa Rao has collaborated with scholars based in India, United States and Australia. Frequent co-authors include Vani Santosh, Jonathan Schug, Klaus H. Kaestner, Arimappamagan Arivazhagan, M. Celeste Simon, Brian Keith, Samuel S. Lee, Lijoy K. Mathew, Nicolas Skuli and Priti Lal. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Cell Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026